Fig. 3From: Different clinical significance of FGFR1–4 expression between diffuse-type and intestinal-type gastric cancerSurvival of patients with intestinal-type gastric cancer. Kaplan-Meier curves for the disease-specific survival of patients with expression of (a) fibroblast growth factor receptor (FGFR)1, (b) FGFR2, (c) FGFR3, and (d) FGFR4Back to article page